Dynavax Technologies Corporation (DVAX)
Largest Insider Buys in Sector
DVAX Stock Price History Chart
DVAX Stock Performance
About Dynavax Technologies Corporation
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. …
Insider Activity of Dynavax Technologies Corporation
Over the last 12 months, insiders at Dynavax Technologies Corporation have bought $0 and sold $457,999 worth of Dynavax Technologies Corporation stock.
On average, over the past 5 years, insiders at Dynavax Technologies Corporation have bought $10M and sold $39.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000,000 shares for transaction amount of $10M was made by Hack Andrew A. F. (director) on 2020‑05‑27.
List of Insider Buy and Sell Transactions, Dynavax Technologies Corporation
| 2024-05-31 | Sale | director | 3,615 0.0027% | $11.93 | $43,127 | -5.38% | ||
| 2024-03-01 | Sale | Chief Accounting Officer | 20,526 0.0157% | $12.78 | $262,322 | -9.08% | ||
| 2024-01-04 | Sale | SVP and CMO | 1,500 0.0012% | $15.00 | $22,500 | -20.18% | ||
| 2024-01-02 | Sale | President & COO | 9,000 0.007% | $14.45 | $130,050 | -16.24% | ||
| 2023-12-01 | Sale | President & COO | 20,000 0.0153% | $13.56 | $271,200 | -12.68% | ||
| 2023-11-03 | Sale | President & COO | 20,000 0.0164% | $15.00 | $300,000 | -15.26% | ||
| 2023-11-01 | Sale | President & COO | 20,000 0.0155% | $14.12 | $282,400 | -14.54% | ||
| 2023-10-10 | Sale | SVP and CMO | 1,755 0.0014% | $15.01 | $26,343 | -16.69% | ||
| 2023-10-02 | Sale | SVP and CMO | 5,015 0.0039% | $15.03 | $75,375 | -17.56% | ||
| 2023-10-02 | Sale | President & COO | 40,000 0.0308% | $14.88 | $595,000 | -17.56% | ||
| 2023-09-01 | Sale | President & COO | 20,000 0.0155% | $14.48 | $289,600 | -12.07% | ||
| 2023-08-24 | Sale | SVP and CMO | 600 0.0005% | $15.02 | $9,012 | -13.00% | ||
| 2023-08-23 | Sale | SVP and CMO | 34,857 0.0271% | $15.01 | $523,204 | -13.81% | ||
| 2023-08-08 | Sale | director | 1.5M 1.1284% | $14.39 | $21.59M | -11.69% | ||
| 2023-08-08 | Sale | SVP and CMO | 2,600 0.002% | $15.05 | $39,130 | -11.69% | ||
| 2023-08-08 | Sale | President & COO | 40,000 0.0311% | $14.87 | $594,900 | -11.69% | ||
| 2023-08-07 | Sale | Chief Accounting Officer | 8,061 0.0062% | $14.54 | $117,247 | -10.46% | ||
| 2023-06-14 | Sale | director | 500,000 0.3927% | $12.68 | $6.34M | +6.26% | ||
| 2023-05-18 | Sale | director | 1M 0.7525% | $10.55 | $10.55M | +22.38% | ||
| 2023-05-04 | Sale | President & COO | 17,515 0.0137% | $10.90 | $190,914 | +22.94% |
Insider Historical Profitability
| Janssen Robert | SVP and CMO | 49925 0.038% | $12.72 | 4 | 20 | +63.59% |
| CANO FRANCIS | director | 36905 0.0281% | $12.72 | 2 | 3 | +47.76% |
| Novack David F | President & COO | 3187 0.0024% | $12.72 | 1 | 22 | +50.89% |
| Hack Andrew A. F. | director | 915000 0.6961% | $12.72 | 1 | 7 | +34.01% |
| ORONSKY ARNOLD L | director | 375055 0.2853% | $12.72 | 2 | 1 | +31.61% |
Institutional Investor Ownership
| BlackRock | $287.8M | 17.72 | 23.19M | -0.88% | -$2.55M | 0.01 | |
| State Street | $131.69M | 8.11 | 10.61M | +11.75% | +$13.85M | 0.01 | |
| The Vanguard Group | $116.68M | 7.18 | 9.4M | +1.36% | +$1.57M | <0.01 | |
| Deep Track Capital Lp | $113.45M | 6.98 | 9.14M | +28.88% | +$25.42M | 0.52 | |
| Federated Hermes | $99.14M | 6.1 | 7.99M | -29.7% | -$41.89M | 0.23 |